# Lisdexamfetamine Dimesylate Capsule: FDA shortage status > FDA source status only. Nationwide status is not local pharmacy inventory. This page does not provide medical, treatment, substitution, or dosing advice. - Derived status: current - Source statuses: Current - FDA package records: 90 - Latest FDA row update: 08/20/2026 - Retrieved: 2026-08-22T15:54:11+00:00 ## FDA package and manufacturer records - Alvogen — Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 47781-562-01) — FDA availability: Available — updated: 08/17/2026 - Alvogen — Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 47781-563-01) — FDA availability: Available — updated: 08/17/2026 - Alvogen — Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 47781-564-01) — FDA availability: Available — updated: 08/17/2026 - Alvogen — Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 47781-565-01) — FDA availability: Available — updated: 08/17/2026 - Alvogen — Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 47781-566-01) — FDA availability: Available — updated: 08/17/2026 - Alvogen — Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 47781-567-01) — FDA availability: Available — updated: 08/17/2026 - Alvogen — Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 47781-568-01) — FDA availability: Available — updated: 08/17/2026 - Amneal Pharmaceuticals — Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 65162-023-09) — FDA availability: Available — updated: 06/17/2026 - Amneal Pharmaceuticals — Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 65162-024-09) — FDA availability: Available — updated: 06/17/2026 - Amneal Pharmaceuticals — Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 65162-025-09) — FDA availability: Available — updated: 06/17/2026 - Amneal Pharmaceuticals — Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 65162-026-09) — FDA availability: Available — updated: 06/17/2026 - Amneal Pharmaceuticals — Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 65162-027-09) — FDA availability: Available — updated: 06/17/2026 - Amneal Pharmaceuticals — Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 65162-028-09) — FDA availability: Available — updated: 06/17/2026 - Apotex Corp. — Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 60505-4739-1) — FDA availability: Available — updated: 08/04/2026 - Apotex Corp. — Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 60505-4740-1) — FDA availability: Limited Availability — updated: 08/04/2026 - Apotex Corp. — Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 60505-4741-1) — FDA availability: Available — updated: 08/04/2026 - Apotex Corp. — Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 60505-4742-1) — FDA availability: Unavailable — updated: 08/04/2026 - Apotex Corp. — Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 60505-4743-1) — FDA availability: Unavailable — updated: 08/04/2026 - Apotex Corp. — Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 60505-4744-1) — FDA availability: Available — updated: 08/04/2026 - Apotex Corp. — Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 60505-4745-1) — FDA availability: Available — updated: 08/04/2026 - Elite Laboratories, Inc. — Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 64850-550-01) — FDA availability: Limited Availability — updated: 08/17/2026 - Elite Laboratories, Inc. — Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 64850-551-01) — FDA availability: Limited Availability — updated: 08/17/2026 - Elite Laboratories, Inc. — Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 64850-552-01) — FDA availability: Limited Availability — updated: 08/17/2026 - Elite Laboratories, Inc. — Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 64850-553-01) — FDA availability: Limited Availability — updated: 08/17/2026 - Elite Laboratories, Inc. — Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 64850-554-01) — FDA availability: Limited Availability — updated: 08/17/2026 - Elite Laboratories, Inc. — Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 64850-555-01) — FDA availability: Limited Availability — updated: 08/17/2026 - Elite Laboratories, Inc. — Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 64850-556-01) — FDA availability: Limited Availability — updated: 08/17/2026 - Hikma Pharmaceuticals USA, Inc. — Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0054-0660-25) — FDA availability: Limited Availability — updated: 05/12/2026 - Hikma Pharmaceuticals USA, Inc. — Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0054-0370-25) — FDA availability: Limited Availability — updated: 08/13/2026 - Hikma Pharmaceuticals USA, Inc. — Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0054-0371-25) — FDA availability: Limited Availability — updated: 08/13/2026 - Hikma Pharmaceuticals USA, Inc. — Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0054-0372-25) — FDA availability: Limited Availability — updated: 08/13/2026 - Hikma Pharmaceuticals USA, Inc. — Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0054-0373-25) — FDA availability: Limited Availability — updated: 08/13/2026 - Hikma Pharmaceuticals USA, Inc. — Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0054-0374-25) — FDA availability: Limited Availability — updated: 08/13/2026 - Hikma Pharmaceuticals USA, Inc. — Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0054-0375-25) — FDA availability: Limited Availability — updated: 08/13/2026 - Lannett Company, Inc. — Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0527-4661-37) — FDA availability: Available — updated: 08/18/2026 - Lannett Company, Inc. — Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0527-4662-37) — FDA availability: Available — updated: 08/18/2026 - Lannett Company, Inc. — Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0527-4663-37) — FDA availability: Available — updated: 08/18/2026 - Lannett Company, Inc. — Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0527-4664-37) — FDA availability: Available — updated: 08/18/2026 - Lannett Company, Inc. — Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0527-4665-37) — FDA availability: Available — updated: 08/18/2026 - Lannett Company, Inc. — Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0527-4666-37) — FDA availability: Available — updated: 08/18/2026 - Lannett Company, Inc. — Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0527-4667-37) — FDA availability: Available — updated: 08/18/2026 - Mylan Pharmaceuticals Inc., a Viatris Company — Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0378-6854-77) — FDA availability: Available — updated: 08/20/2026 - Mylan Pharmaceuticals Inc., a Viatris Company — Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0378-6855-77) — FDA availability: Available — updated: 08/20/2026 - Mylan Pharmaceuticals Inc., a Viatris Company — Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0378-6856-77) — FDA availability: Available — updated: 08/20/2026 - Mylan Pharmaceuticals Inc., a Viatris Company — Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0378-6857-77) — FDA availability: Available — updated: 08/20/2026 - Mylan Pharmaceuticals Inc., a Viatris Company — Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0378-6858-77) — FDA availability: Available — updated: 08/20/2026 - Mylan Pharmaceuticals Inc., a Viatris Company — Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0378-6859-77) — FDA availability: Available — updated: 08/20/2026 - Mylan Pharmaceuticals Inc., a Viatris Company — Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0378-6860-77) — FDA availability: Available — updated: 08/20/2026 - Rhodes Pharmaceuticals L.P. — Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 42858-161-01) — FDA availability: Available — updated: 06/24/2026 - Rhodes Pharmaceuticals L.P. — Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 42858-162-01) — FDA availability: Limited Availability — updated: 06/24/2026 - Rhodes Pharmaceuticals L.P. — Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 42858-163-01) — FDA availability: Limited Availability — updated: 06/24/2026 - Rhodes Pharmaceuticals L.P. — Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 42858-164-01) — FDA availability: Limited Availability — updated: 06/24/2026 - Rhodes Pharmaceuticals L.P. — Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 42858-165-01) — FDA availability: Limited Availability — updated: 06/24/2026 - Rhodes Pharmaceuticals L.P. — Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 42858-166-01) — FDA availability: Available — updated: 06/24/2026 - Rhodes Pharmaceuticals L.P. — Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 42858-167-01) — FDA availability: Limited Availability — updated: 06/24/2026 - Solco Healthcare US, LLC — Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 43547-602-10) — FDA availability: Limited Availability — updated: 06/29/2026 - Solco Healthcare US, LLC — Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 43547-603-10) — FDA availability: Limited Availability — updated: 06/29/2026 - Solco Healthcare US, LLC — Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 43547-604-10) — FDA availability: Limited Availability — updated: 06/29/2026 - Solco Healthcare US, LLC — Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 43547-605-10) — FDA availability: Limited Availability — updated: 06/29/2026 - Solco Healthcare US, LLC — Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 43547-606-10) — FDA availability: Limited Availability — updated: 06/29/2026 - Solco Healthcare US, LLC — Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 43547-607-10) — FDA availability: Limited Availability — updated: 06/29/2026 - Solco Healthcare US, LLC — Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 43547-608-10) — FDA availability: Limited Availability — updated: 06/29/2026 - SpecGx LLC — Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0406-5111-01) — FDA availability: Available — updated: 08/20/2026 - SpecGx LLC — Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0406-5112-01) — FDA availability: Available — updated: 08/20/2026 - SpecGx LLC — Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0406-5113-01) — FDA availability: Available — updated: 08/20/2026 - SpecGx LLC — Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0406-5114-01) — FDA availability: Available — updated: 08/20/2026 - SpecGx LLC — Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0406-5115-01) — FDA availability: Available — updated: 08/20/2026 - SpecGx LLC — Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0406-5116-01) — FDA availability: Available — updated: 08/20/2026 - SpecGx LLC — Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0406-5117-01) — FDA availability: Available — updated: 08/20/2026 - Sun Pharmaceutical Industries, Inc. — Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 57664-046-88) — FDA availability: Limited Availability — updated: 08/05/2026 - Sun Pharmaceutical Industries, Inc. — Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 57664-048-88) — FDA availability: Limited Availability — updated: 08/05/2026 - Sun Pharmaceutical Industries, Inc. — Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 57664-048-88) — FDA availability: Limited Availability — updated: 08/05/2026 - Sun Pharmaceutical Industries, Inc. — Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 57664-049-88) — FDA availability: Limited Availability — updated: 08/05/2026 - Sun Pharmaceutical Industries, Inc. — Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 57664-050-88) — FDA availability: Limited Availability — updated: 08/05/2026 - Sun Pharmaceutical Industries, Inc. — Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 57664-051-88) — FDA availability: Limited Availability — updated: 08/05/2026 - Sun Pharmaceutical Industries, Inc. — Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 57664-052-88) — FDA availability: Limited Availability — updated: 08/05/2026 - Takeda Pharmaceuticals USA Inc. — Vyvanse, Capsule, 10 mg (NDC 59417-101-10) — FDA availability: Available — updated: 06/23/2026 - Takeda Pharmaceuticals USA Inc. — Vyvanse, Capsule, 20 mg (NDC 59417-102-10) — FDA availability: Available — updated: 06/23/2026 - Takeda Pharmaceuticals USA Inc. — Vyvanse, Capsule, 30 mg (NDC 59417-103-10) — FDA availability: Available — updated: 06/23/2026 - Takeda Pharmaceuticals USA Inc. — Vyvanse, Capsule, 40 mg (NDC 59417-104-10) — FDA availability: Available — updated: 06/23/2026 - Takeda Pharmaceuticals USA Inc. — Vyvanse, Capsule, 50 mg (NDC 59417-105-10) — FDA availability: Available — updated: 06/23/2026 - Takeda Pharmaceuticals USA Inc. — Vyvanse, Capsule, 60 mg (NDC 59417-106-10) — FDA availability: Available — updated: 06/23/2026 - Takeda Pharmaceuticals USA Inc. — Vyvanse, Capsule, 70 mg (NDC 59417-107-10) — FDA availability: Available — updated: 06/23/2026 - Teva Pharmaceuticals USA, Inc. — Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0480-3565-01) — FDA availability: Available — updated: 08/17/2026 - Teva Pharmaceuticals USA, Inc. — Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0480-3566-01) — FDA availability: Available — updated: 08/17/2026 - Teva Pharmaceuticals USA, Inc. — Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0480-3567-01) — FDA availability: Available — updated: 08/17/2026 - Teva Pharmaceuticals USA, Inc. — Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0480-3568-01) — FDA availability: Available — updated: 08/17/2026 - Teva Pharmaceuticals USA, Inc. — Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0480-3569-01) — FDA availability: Available — updated: 08/17/2026 - Teva Pharmaceuticals USA, Inc. — Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0480-3570-01) — FDA availability: Available — updated: 08/17/2026 - Teva Pharmaceuticals USA, Inc. — Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0480-3564-01) — FDA availability: Available — updated: 08/17/2026 ## Sources and formats - [FDA openFDA source](https://api.fda.gov/drug/shortages.json) - [Canonical HTML](https://citefacts.com/shortages/lisdexamfetamine-dimesylate-capsule) - [JSON record](https://citefacts.com/shortages/lisdexamfetamine-dimesylate-capsule.json)